183 related articles for article (PubMed ID: 36344177)
21. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
[TBL] [Abstract][Full Text] [Related]
23. Precursor lesions of prostate cancer.
Chrisofos M; Papatsoris AG; Lazaris A; Deliveliotis C
Crit Rev Clin Lab Sci; 2007; 44(3):243-70. PubMed ID: 17453919
[TBL] [Abstract][Full Text] [Related]
24. Atypical cribriform lesions on prostate biopsy.
Kronz JD; Shaikh AA; Epstein JI
Am J Surg Pathol; 2001 Feb; 25(2):147-55. PubMed ID: 11176063
[TBL] [Abstract][Full Text] [Related]
25. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.
Rubin MA; de La Taille A; Bagiella E; Olsson CA; O'Toole KM
Am J Surg Pathol; 1998 Jul; 22(7):840-8. PubMed ID: 9669346
[TBL] [Abstract][Full Text] [Related]
26. My approach to intraductal lesions of the prostate gland.
Pickup M; Van der Kwast TH
J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
[TBL] [Abstract][Full Text] [Related]
27. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
[TBL] [Abstract][Full Text] [Related]
28. Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia.
Merrimen JL; Evans AJ; Srigley JR
Pathology; 2013 Apr; 45(3):251-63. PubMed ID: 23478231
[TBL] [Abstract][Full Text] [Related]
29. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
[TBL] [Abstract][Full Text] [Related]
30. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
[TBL] [Abstract][Full Text] [Related]
31. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
[TBL] [Abstract][Full Text] [Related]
32. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
33. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Kench JG; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Moch H; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tsuzuki T; Turjalic S; van der Kwast TH; Zhou M; Srigley JR
Histopathology; 2022 Oct; 81(4):447-458. PubMed ID: 35758185
[TBL] [Abstract][Full Text] [Related]
34. Intraductal carcinoma of the prostate.
Robinson B; Magi-Galluzzi C; Zhou M
Arch Pathol Lab Med; 2012 Apr; 136(4):418-25. PubMed ID: 22458904
[TBL] [Abstract][Full Text] [Related]
35. In-Depth Comparison of Genetic Variants Demonstrates a Close Relationship Between Invasive and Intraductal Components of Prostate Cancer.
Vormittag-Nocito E; Acosta AM; Agarwal S; Narayan KD; Kumar R; Al Rasheed MRH; Kajdacsy-Balla A; Behm FG; Mohapatra G
Mod Pathol; 2023 Jun; 36(6):100130. PubMed ID: 36933394
[TBL] [Abstract][Full Text] [Related]
36. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
Botticelli AR
Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
[TBL] [Abstract][Full Text] [Related]
37. Premalignancy in Prostate Cancer: Rethinking What we Know.
De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
[TBL] [Abstract][Full Text] [Related]
38. Histomorphological study of prostatic adenocarcinoma and its mimics.
Mahapatra QS; Mohanty P; Nanda A; Mohanty L
Indian J Pathol Microbiol; 2019; 62(2):251-260. PubMed ID: 30971549
[TBL] [Abstract][Full Text] [Related]
39. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
40. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
Rekhi B; Jaswal TS; Arora B
Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
